Medicure Inc. (CVE:MPH – Get Free Report) shares reached a new 52-week low on Monday . The company traded as low as C$0.99 and last traded at C$0.99, with a volume of 3300 shares. The stock had previously closed at C$1.03.
Medicure Price Performance
The stock has a market capitalization of C$10.15 million, a price-to-earnings ratio of 11.00 and a beta of 1.01. The company has a quick ratio of 1.29, a current ratio of 2.28 and a debt-to-equity ratio of 2.86. The business has a 50-day simple moving average of C$1.15 and a two-hundred day simple moving average of C$1.35.
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Recommended Stories
- Five stocks we like better than Medicure
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- GE Aerospace is Ready for Liftoff After Strong Earnings
- Insider Selling Explained: Can it Inform Your Investing Choices?
- The Bottom is in For Tesla: Read This Before Buying the Bounce
- How to Invest in the Best Canadian Stocks
- 3 Technologies to Challenge NAND Flash Dominance in AI
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
